Citation 82887

MIMAKI,Y: SATOU,T: KURODA,M: SASHIDA,Y: HATAKEYAMA,Y:. (1998). NEW STEROIDAL CONSTITUENTS FROM THE BULBS OF LILIUM CANDIDUM.. 46(11)

Citation Details

Title	NEW STEROIDAL CONSTITUENTS FROM THE BULBS OF LILIUM CANDIDUM.
Authors	MIMAKI,Y: SATOU,T: KURODA,M: SASHIDA,Y: HATAKEYAMA,Y:
Year	1998
Volume	46
Issue	11

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Lilium candidum (LILIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROST-5-ENE-3-BETA-17-ALPHA-DIOL,26-METHOXY: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE(25R-26R):	None
2	ATP-ASE(NA+/K+) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROST-5-ENE-3-BETA-17-ALPHA-DIOL,26-METHOXY: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE(25R-26R):	INACTIVE
3	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	SPIROST-5-EN-3-BETA-OL,26-METHOXY: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE] (25R-26R):	None
4	ATP-ASE(NA+/K+) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROST-5-EN-3-BETA-OL,26-METHOXY: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE] (25R-26R):	ACTIVE
5	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	DIOSGENIN-3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE] 25(R):	None
6	ATP-ASE(NA+/K+) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSGENIN-3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE] 25(R):	ACTIVE
7	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	SPIROST-5-EN-3-BETA-OL,26-METHOXY: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE] (25R-26R):	None
8	ATP-ASE(NA+/K+) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROST-5-EN-3-BETA-OL,26-METHOXY: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE] (25R-26R):	ACTIVE
9	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROST-5-ENE-3-BETA-17-ALPHA-DIOL,26-METHOXY: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[6-O-ACETYL-BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE (25R-26R):	None
10	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	NARTHOGENIN,ISO: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE] 25(S):	None
11	ATP-ASE(NA+/K+) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROST-5-ENE-3-BETA-17-ALPHA-DIOL,26-METHOXY: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[6-O-ACETYL-BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE (25R-26R):NARTHOGENIN,ISO: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE] 25(S):	INACTIVE
12	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROST-5-ENE-3-BETA-17-ALPHA-DIOL,26-METHOXY: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE] (25R-26R):	None
13	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	NARTHOGENIN,ISO: 3-O-[O-BETA-D-GLUCOPYRANOSYL(1-3)-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE	None
14	ATP-ASE(NA+/K+) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROST-5-ENE-3-BETA-17-ALPHA-DIOL,26-METHOXY: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE] (25R-26R):NARTHOGENIN,ISO: 3-O-[O-BETA-D-GLUCOPYRANOSYL(1-3)-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE	INACTIVE
15	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FUROST-5-ENE-3-BETA-22-EPSILON-26-TRIOL,26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL: 3-O-[O-ALPHA-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE] 25(R):	None
16	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FUROST-5-ENE-3-BETA-22-EPSILON-26-TRIOL,26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL: 3-O-[O-ALPHA-LPRHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE 25(R):	None
17	ATP-ASE(NA+/K+) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROST-5-ENE-3-BETA-22-EPSILON-26-TRIOL,26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL: 3-O-[O-ALPHA-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE] 25(R):FUROST-5-ENE-3-BETA-22-EPSILON-26-TRIOL,26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL: 3-O-[O-ALPHA-LPRHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE 25(R):	ACTIVE

Show SPARQL Queries (1)